N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents: Synthesis and biological evaluation-Reference-Cited by-同舟云学术

N-2-(phenylamino) benzamide derivatives as novel anti-glioblastoma agents: Synthesis and biological evaluation

Published:2021-12 Issue: Volume:226 Page:113817
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Li Junfang,Hu Xiaoling,Luo Tian,Lu Yingmei,Feng Yiyue,Zhang Honghua,Liu Dan,Fan Xiaohong,Wang Yuqing,Jiang Liming,Wang Yuying,Hao Xiangyong,Shi Tao,Wang Zhen^ORCID

Funder

Fundamental Research Funds for the Central Universities

Lanzhou University

Natural Science Foundation for Distinguished Young Scholars of Hunan Province

Ministry of Education of the People's Republic of China

Recruitment Program of Global Experts

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference88 articles.

1. Management of glioblastoma: state of the art and future directions;Tan;Ca-a Canc. J. Clinic.,2020

2. Small molecule kinase inhibitors for the treatment of brain cancer;Heffron;J. Med. Chem.,2016

3. B. European Org Res Treatment Canc, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N. Engl. J. Med.,2005

4. Pediatric high-grade glioma: biologically and clinically in need of new thinking;Jones;Neuro Oncol.,2017

5. Multi-target therapeutics: when the whole is greater than the sum of the parts;Zimmermann;Drug Discov. Today,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery, synthesis, and anti-cancer evaluation of 10-Pterostilbene methylamine hydrochloride derivatives as potential COX-2 and Topo I dual inhibitors;Journal of Molecular Structure;2024-09

2. A Phyto-mycotherapeutic Supplement, Namely Ganostile, as Effective Adjuvant in Brain Cancer Management: An In Vitro Study Using U251 Human Glioblastoma Cell Line;International Journal of Molecular Sciences;2024-06-05

3. Dual-target inhibitors based on COX-2: a review from medicinal chemistry perspectives;Future Medicinal Chemistry;2023-12

4. Discovery of dual inhibitors of topoisomerase I and Cyclooxygenase-2 for colon cancer therapy;European Journal of Medicinal Chemistry;2022-10

5. N-2-(Phenylamino) Benzamide Derivatives as Dual Inhibitors of COX-2 and Topo I Deter Gastrointestinal Cancers via Targeting Inflammation and Tumor Progression;Journal of Medicinal Chemistry;2022-07-22